Oncternal Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Oncternal Therapeutics Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Oncternal Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Oncternal Therapeutics Inc.

Back to companies

Oncternal Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item
Gain a 360-degree view of Oncternal Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Oncternal Therapeutics Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address Suite 230, 12230 El Camino Real, San Diego, California, 92130
Website www.oncternal.com
Telephone 1 858 4341113
No of Employees 27
Industry Pharmaceuticals and Healthcare
Revenue (2023) $785,000
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Oncternal Therapeutics Inc premium industry data and analytics

40+

Clinical Trials

Determine Oncternal Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Oncternal Therapeutics Inc’s relevant decision makers and contact details.

20+

Pipeline Drugs

Identify which of Oncternal Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Catalyst Calendar

Proactively evaluate Oncternal Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

10+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Oncternal Therapeutics Inc key executives to enhance your sales strategy Gain insight into Oncternal Therapeutics Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?